X

Medscape

Medscape
Many Breast Cancer Patients Use Cannabis for Symptom Relief

A new survey of US patients with breast cancer found that 42% were using cannabis, primarily to relieve side effects associated with treatment, such as pain, anxiety, nausea, and insomnia. 

Medscape
10/21/2021
Chronic Stress Hard on Women With Breast Cancer

Physiologic "wear and tear" from lifelong exposure to stressors was associated with a decreased likelihood of completing chemotherapy and a lower overall survival in breast cancer patients. 

Medscape
10/11/2021
FDA Approves Pembrolizumab Plus Chemo as First-Line Therapy for Advanced, Recurrent Cervical Cancer

The FDA has approved the checkpoint inhibitor pembrolizumab alongside standard chemotherapy, as first-line therapy for patients with PD-L1-expressing cervical cancer.

Medscape
10/13/2021
Rising Rates of Esophageal Cancer in Young Adults; Lifestyle May Be to Blame

Increased rates of esophageal adenocarcinoma could reflect changes in lifestyle-related risk factors for the disease, with rises in unhealthy habits including smoking, poor diet...

Medscape
10/11/2021
Unexpected Thrombocytosis Could Flag Occult Cancer

A finding of thrombocytosis was associated with a greatly increased risk for some cancers up to 5 years later.

Medscape
10/04/2021
NCCN Guidelines Embrace PSMA-PET Imaging for Prostate Cancer

A reference in the newly updated prostate cancer guidelines from the NCCN has prostate cancer specialists excited about the prospects for incorporating PSMA-PET into daily practice.

Medscape
09/28/2021
Abiraterone Also Ups Survival in Nonmetastatic Prostate Cancer

Scientists find clinical use for the combination of abiraterone acetate and ADT for the treatment of men with high-risk, nonmetastatic prostate cancer.

Medscape
09/23/2021
FDA Approves Cabozantinib for Differentiated Thyroid Cancer

The FDA approves Cabozantinib, indicated for patients whose disease has progressed after they have received VEGFR-targeted therapy...

Medscape
09/22/2021
Androgen Deprivation Alone No Longer Acceptable for mCSPC

New results from the PEACE-1 trial show that regardless of the standard-of-care regimen used, the addition of abiraterone (Zytiga) has a "clinically meaningful impact on survival."

Medscape
09/20/2021
FDA Approves First Oral Drug for NSCLC With EGFR Exon20 Insertion

The FDA grants accelerated approval to mobocertinib for the treatment of patients with locally advanced or metastatic non–small-cell lung cancer with EGFR exon 20 insertion mutations.

Medscape
09/16/2021
Subscribe to Medscape

source list reference

rgb(171, 222, 222)
#7d60d9
#2694a4
#32a887
200, 66, 245
#85eb24
rgb(195, 2, 230)
#352625
#4d4537
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
#d2093c
#8e3f1c
rgb(242, 0, 137)
#76b6c3
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
#bfcfc8
rgb (252, 186, 3)
#c61417
rgb(156, 242, 7)
#67e25b
#efef71
#03cffc
rgb(224, 4, 129)
#42fc9a
rgb(80, 147, 199)
#cc529a
#c59445
#c8cc0c
#bf6be3
#e8085a
#97d1a0
#74e391
#eb6342
#b61f77
#a153ac
rgb(5, 235, 235)
#e7f6e3
#6fc969
#9a8c2c
#a9c507
rgb(235, 190, 9)
#2b9ab3
#e61923
rgb(209, 227, 11)
#990677
#4a7bab
200, 66, 245
#89f67c
#49a21d
rgb (132, 101, 173)
#2c990a
#d7da81
#f5ce42
rgb(217, 7, 192)
#575662
#a60538
rgb(2, 230, 230)
#49cde9
#c20fce
rgb(80,199,199)
#d95d39
#eb5834